Cargando…
Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer
Background: Irinotecan (CPT-11) can be used as a first-line therapeutic drug against extensive-stage small cell lung cancer (SCLC); it can also be used in second-line treatment for SCLC. CPT-11-induced delayed diarrhea restricts its clinical application. This study aimed to confirm whether Banxia Xi...
Autores principales: | Lu, Hongyang, Qin, Jing, Han, Na, Xie, Fajun, Gong, Lei, Li, Chenghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247536/ https://www.ncbi.nlm.nih.gov/pubmed/30229683 http://dx.doi.org/10.1177/1534735418801532 |
Ejemplares similares
-
Banxia Xiexin decoction: A review on phytochemical, pharmacological, clinical and pharmacokinetic investigations
por: Zhou, Zehua, et al.
Publicado: (2023) -
Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats
por: Deng, Chao, et al.
Publicado: (2017) -
Efficacy of Banxia Xiexin decoction for chronic atrophic gastritis: A systematic review and meta-analysis
por: Cao, Yang, et al.
Publicado: (2020) -
Banxia Xiexin Decoction in the treatment of chronic atrophic gastritis: A protocol for systematic review and meta-analysis
por: Ji, Qing, et al.
Publicado: (2020) -
Effectiveness of Banxia Xiexin Decoction in the treatment of precancerous lesions: A protocol for systematic review and meta-analysis
por: Yi, Ying, et al.
Publicado: (2021)